The airline restored its full-year outlook after pulling back in April. Transcript: CAROLINE WOODS: Delta shares are taking off after its latest quarterly results came in better than expected.
Streaming name and Schaeffer's Top 2025 Stock Pick Roku Inc (NASDAQ:ROKU) is up 0.8% to trade at $89.33, after landing an upgrade out of Keybanc to "overweight" from "sector weight" to go with a $115 price target.
Helen of Troy Stock Sinks as Firm Posts Slowing Sales, Rues Tariff Impacts — Negative
HELE Investopedia — July 10, 2025Helen of Troy Ltd. (HELE) shares plunged 25% Thursday when the maker of consumer healthcare and home products posted weaker-than-expected results and guidance, which it blamed on slowing sales and the impact of new U.S. tariffs.
Beam Therapeutics (BEAM) Surges 5.7%: Is This an Indication of Further Gains? — Positive
BEAM Zacks Investment Research — July 10, 2025Beam Therapeutics (BEAM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
TTD Declines 23% in a Year: Continue to Hold or Sell the Stock? — Negative
TTD Zacks Investment Research — July 10, 2025The Trade Desk TTD, a well-known name in the programmatic advertising space, has seen its stock take a significant hit. The stock price has declined 23.3% over the past year, underperforming the Zacks Internet Services industry's decline of 1.9%.
UUUU Gains 36% in the Past 3 Months: Buy, Sell or Hold the Stock? — Negative
UUUU Zacks Investment Research — July 10, 2025Energy Fuels is up 36% in three months on strong uranium output, but a stretched valuation and 2025 loss forecast raise red flags.
RTX Stock: Does Barracuda Anti-Mine's Success Signal a Buying Opportunity? — Neutral
RTX Zacks Investment Research — July 10, 2025Barracuda's breakthrough shows RTX's tech edge, but supply woes, weak outlook and high valuation raise red flags.
Rhythm Pharmaceuticals (RYTM) Stock Jumps 36.6%: Will It Continue to Soar? — Positive
RYTM Zacks Investment Research — July 10, 2025Rhythm Pharmaceuticals (RYTM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here's when the Tesla shareholder meeting is happening — and why it matters — Neutral
TSLA Market Watch — July 10, 2025After being called out by a group of investors, Tesla has set a date for its annual gathering.
Kayne Anderson BDC, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call — Neutral
KBDC Business Wire — July 10, 2025CHICAGO--(BUSINESS WIRE)--Kayne Anderson BDC, Inc. (NYSE: KBDC) (“KBDC”), a business development company externally managed by its investment adviser, KA Credit Advisors, LLC, announced today that it will release its financial results for the second quarter ended June 30, 2025 on Monday, August 11, 2025, after the close of financial markets. KBDC will host a conference call at 10:00 am ET on Tuesday, August 12, 2025, to review its financial results. All interested parties are invited to partici.
How you're thinking about streaming and fragmentation
DULUTH, Ga. , July 10, 2025 /PRNewswire/ -- AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, announced its Board of Directors declared a regular quarterly dividend of $0.29 per common share to be paid on September 15, 2025, to all stockholders of record as of the close of business August 15, 2025.
Growth in NII, Fee Income to Support BNY Mellon's Q2 Earnings — Positive
BK Zacks Investment Research — July 10, 2025BK's Q2 earnings are set to rise as fee revenues, FX gains and stronger NII offset rising expense pressures.
Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Positive
ABT Zacks Investment Research — July 10, 2025Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Texas Capital (TCBI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Positive
TCBI Zacks Investment Research — July 10, 2025Texas Capital (TCBI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fundstrat's Tom Lee: Nvidia being the most valuable company in the S&P makes a lot of sense — Positive
NVDA CNBC Television — July 10, 2025Tom Lee, Fundstrat head of research and CIO, joins CNBC's 'Squawk on the Street' to discuss outlooks on Nvidia, whether there may be catalysts to the upside, and much more.
Earnings Preview: Elevance Health (ELV) Q2 Earnings Expected to Decline — Negative
ELV Zacks Investment Research — July 10, 2025Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral
MMC Zacks Investment Research — July 10, 2025Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Citizens Financial Group (CFG) Earnings Expected to Grow: Should You Buy? — Positive
CFG Zacks Investment Research — July 10, 2025Citizens Financial Group (CFG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
